A case of pure red cell aplasia during nivolumab therapy for cardiac metastatic melanoma-Reference-Cited by-同舟云学术

A case of pure red cell aplasia during nivolumab therapy for cardiac metastatic melanoma

Published:2017-12 Issue:6 Volume:27 Page:635-637
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Yuki Akihiko,Takenouchi Tatsuya,Takatsuka Sumiko,Ishiguro Takuro

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference14 articles.

1. Managing immune checkpoint-blocking antibody side effects;Postow;Am Soc Clin Oncol Educ Book,2015

2. Immunotherapy-associated autoimmune hemolytic anemia;Khan;J Immunother Cancer,2017

3. Autoimmune hemolytic anemia induced by anti-PD-1 therapy in metastatic melanoma;Kong;Melanoma Res,2016

4. Development of hemolytic anemia in a nivolumab-treated patient with refractory metastatic squamous cell skin cancer and chronic lymphatic leukemia;Schwab;Case Rep Oncol,2016

5. Autoimmune hemolytic anemia after nivolumab treatment in Hodgkin lymphoma responsive to immunosuppressive treatment. A case report;Tardy;Hematol Oncol,2016

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pure Red Cell Aplasia and Chromosomal Abnormality in a Patient With Lung Adenocarcinoma Receiving Immune Checkpoint Inhibitors: A Case Report;In Vivo;2024

2. Pure Red Cell Aplasia Induced by Atezolizumab in a Patient with Small-Cell Lung Cancer Successfully Treated with Steroid Therapy: A Case Report;Case Reports in Oncology;2023-12-18

3. Immune Checkpoint Inhibitor-Induced Pure Red Cell Aplasia: A Review of 2 Cases in Metastatic Melanoma;American Journal of Case Reports;2023-10-14

4. Waldenström macroglobulinemia with secondary pure red cell aplasia in a patient with metastatic castrate resistant prostate cancer receiving an immune checkpoint inhibitor: a case report;Journal of Medical Case Reports;2023-05-28

5. Antithymocyte globulin for aplastic anemia secondary to pembrolizumab: a case report and review of literature;Immunotherapy;2023-04